Platelet endothelial cell adhesion molecule deficiency or blockade significantly reduces leukocyte emigration in a majority of mouse strains

Journal of Immunology

Volumn 173, Issue 10, 2004, Pages 6403-6408

  Schenkel, Alan R ^a   Chew, Tina W ^b   Muller, William A ^b  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CELL ADHESION MOLECULE; HYBRID PROTEIN; PLATELET ENDOTHELIAL CELL ADHESION MOLECULE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; INFLAMMATION; KNOCKOUT MOUSE; LEUKOCYTE MIGRATION; MONOCYTE; MOUSE; MOUSE STRAIN; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

EID: 8444224950     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.10.6403     Document Type: Article

References (28)

1. Newman, P. J., M. C. Berndt, J. Gorski, G. C. White II, S. Lyman, C. Paddock, and W. A. Muller. 1990. PECAM-1 [CD31] cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 247:1219.
2. Liao, F., H. K. Huynh, A. Eiroa, T. Greene, E. Polizzi, and W. A. Muller. 1995. Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1. J. Exp. Med. 182:1337.
3. Mamdouh, Z., X. Chen, L. M. Pierini, F. R. Maxfield, and W. A. Muller. 2003. Targeted recycling of PECAM from endothelial surface-connected compartments during diapedesis. Nature 421:748.
4. Jackson, D. E., K. R. Kupcho, and P. J. Newman. 1997. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of platelet/endothelial cell adhesion molecule-1 (PECAM-1) that are required for the cellular association and activation of the protein-tyrosine phosphatase, SHP-2. J. Biol. Chem. 272:24868.
5. Jackson, D. E., C. M. Ward, R. Wang, and P. J. Newman. 1997. The protein-tyrosine phosphatase SHP-2 binds platelet/endothelial cell adhesion molecule-1 (PECAM-1) and forms a distinct signaling complex during platelet aggregation. J. Biol. Chem. 272:6986.
6. Muller, W. A., S. A. Weigl, X. Deng, and D. M. Phillips. 1993. PECAM-1 is required for transendothelial migration of leukocytes. J. Exp. Med. 178:449.
7. Vaporciyan, A. A., H. M. Delisser, H.-C. Yan, I. I. Mendiguren, S. R. Thorn, M. L. Jones, P. A. Ward, and S. M. Albelda. 1993. Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science 262:1580.
8. Bogen, S., J. Pak, M. Garifallou, X. Deng, and W. A. Muller. 1994. Monoclonal antibody to murine PECAM-1 [CD31] blocks acute inflammation in vivo. J. Exp. Med. 179:1059.
9. Muller, W. A. 1995. The role of PECAM-1 [CD31] in leukocyte emigration: studies in vitro and in vivo. J. Leukocyte Biol. 57:523.
10. Liao, F., J. Ali, T. Greene, and W. A. Muller. 1997. Soluble domain 1 of platelet-endothelial cell adhesion molecule (PECAM) is sufficient to block transendothelial migration in vitro and in vivo. J. Exp. Med. 185:1349.
11. Liao, F., A. R. Schenkel, and W. A. Muller. 1999. Transgenic mice expressing different levels of soluble platelet/endothelial cell adhesion molecule-IgG display distinct inflammatory phenotypes. J. Immunol. 163:5640.
12. Thompson, R. D., K. E. Noble, K. Y. Larbi, A. Dewar, G. S. Duncan, T. W. Mak, and S. Nourshargh. 2001. Platelet-endothelial cell adhesion molecule-1 (PE-CAM-1)-deficient mice demonstrate a transient and cytokine-specific role for PECAM-1 in leukocyte migration through the perivascular basement membrane. Blood 97:1854.
13. Qing, Z., M. Sandor, Z. Radvany, D. Sewell, A. Falus, D. Potthoff, W. A. Muller, and Z. Fabry. 2001. Inhibition of antigen-specific T cell trafficking into the central nervous system via blocking PECAM1/CD31 molecule. J. Neuropathol. Exp. Neural 60:798.
14. Duncan, G. S., D. P. Andrew, H. Takimoto, S. A. Kaufman, H. Yoshida, J. Spellberg, J. L. de la Pompa, A. Elia, A. Wakeham, B. Karan-Tamir, et al. 1999. Genetic evidence for functional redundancy of platelet/endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. J. Immunol. 162:3022.
15. Mahooti, S., D. Graesser, S. Patil, P. Newman, G. Duncan, T. Mak, and J. A. Madri. 2000. PECAM-1 (CD31) expression modulates bleeding time in vivo. Am. J. Pathol. 157:75.
16. Graesser, D., A. Solowiej, M. Bruckner, E. Osterweil, A. Juedes, S. Davis, N. H. Ruddle, B. Engelhardt, and J. A. Madri. 2002. Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. J. Clin. Invest. 109:383.
17. Solowiej, A., P. Biswas, D. Graesser, and J. A, Madri. 2003. Lack of platelet endothelial cell adhesion molecule-1 attenuates foreign body inflammation because of decreased angiogenesis. Am. J. Pathol. 162:953.
18. Festing, M. F. W. 1998. Inbred strains of mice: C57BL. In Inbred Strains of Mice. Jackson Laboratory, Bar Harbor, ME.
19. Ishikaw, J., Y. Okada, I. N. Bird, B. Jasani, J. H. Spragg, and T. Yamada. 2002. Use of anti-platelet-endothelial cell adhesion molecule-1 antibody in the control of disease progression in established collagen-induced arthritis in DBA/1 J mice. Jpn. J. Pharmacol. 88:332.
20. Decking, J., A. Mayer, P. Petrow, D. Seiffge, and A. Karbowski. 2001. Antibodies to PECAM-1 and glucocorticoids reduce leukocyte adhesion in adjuvant arthritis of the rat knee synovium in vivo. Inflamm. Res. 50:609.
21. Tucker, P. K., B. K. Lee, B. L. Lundrigan, and E. M. Eicher. 1992. Geographic origin of the Y chromosomes in "old" inbred strains of mice. Mamm. Genome 3:254.
22. Rikke, B. A., Y. Zhao, L. P. Daggett, R. Reyes, and S. C. Hardies. 1995. Mus spretus LINE-1 sequences detected in the Mus musculus inbred strain C57BL/6J using LINE-1 DNA probes. Genetics 139:901.
23. Kalcheva, I. D., Y. Matsuda, C. Plass, and V. M. Chapman. 1995. Isolation and characterization of a pseudoautosomal region-specific genetic marker in C57BL/6 mice using genomic representational difference analysis. Proc. Natl. Acad. Sci. USA 92:12352.
24. Schenkel, A. R., Z. Mamdouh, X. Chen, R. M. Liebman, and W. A. Muller. 2002. CD99 plays a major role in the migration of monocytes through endothelial junctions. Nat. Immunol. 3:143.
25. Dansky, H. M., P. Shu, M. Donavan, J. Montagno, D. L. Nagle, J. S. Smutko, N. Roy, S. Whiteing, J. Barrios, T. J. McBride, et al. 2002. A phenotype-sensitizing Apoe-deficient genetic background reveals novel atherosclerosis predisposition loci in the mouse. Genetics 160:1599.
26. Smith, J. D., H. M. Dansky, and J. L. Breslow. 2001. Genetic modifiers of atherosclerosis in mice. Ann. NY Acad. Sci. 947:247.
27. Smith, J. D., D. James, H. M. Dansky, K. M. Wittkowski, K. J. Moore, and J. L. Breslow. 2003. In silico quantitative trait locus map for atherosclerosis susceptibility in apolipoprotein E-deficient mice. Anerioscler. Thromb. Vasc. Biol. 23:117.
28. Idel, S., H. M. Dansky, and J. L. Breslow. 2003. A20, a regulator of NFκB, maps to an atherosclerosis locus and differs between parental sensitive C57BL/6J and resistant FVB/N strains. Proc. Natl. Acad. Sci. USA 100:14235.